Nordic Pharma Consulting ApS: Financial statements 2023
CVR: 37368598
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Nordic Pharma Consulting ApS (CVR 37368598) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 11,213,012 and a net result of DKK 1,588,832 compared with DKK 3,594,582 the year before. That is a decrease of 3.5% compared with the year before. Equity in the 2023 report amounted to DKK 2,391,429. The solvency ratio was 45.9%. The company had 7 employees in the financial year.
- Gross Profit
- DKK 11,213,012
- Profit/Loss
- DKK 1,588,832
- Equity
- DKK 2,391,429
- Total Assets
- DKK 5,206,870
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 11.2M | 1.6M | 2.4M | 7 |
| 2022 | - | 11.6M | 3.6M | 4.4M | 6 |
| 2021 | - | 8.8M | 1.8M | 2.6M | 6 |
| 2020 | - | 8.9M | 1.5M | 2.3M | 5 |
| 2019 | - | 8.6M | 752K | 803K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Nordic Pharma Consulting ApS has published its annual report for 2022. Gross profit came to DKK 11,622,261, and the net result was DKK 3,594,582.
As of March 15, 2023, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has been appointed auditor of Nordic Pharma Consulting ApS.
As of March 15, 2023, 18. juni 2024 P/S has stepped down as auditor of Nordic Pharma Consulting ApS.
About Nordic Pharma Consulting ApS
Nordic Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2016. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Bill Madsen and Ray David Sossna. The company is owned by Bill Holding ApS and by.david ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 15,902,080 and a net result of DKK 3,684,788 compared with DKK 2,966,376 the year before. Equity in the 2025 report amounted to DKK 4,487,385.